In the increasingly cost-contained world of medical device market access, Payers (including Ministries of Health, Insurers private & public, Hospitals and local governments) are seeking to justify investment in new medical technologies. Health Technology Assessment (HTA) agencies are now widely spread across Europe assess new technologies and interventions not only on the grounds of clinical effectiveness, but also based on cost-effectiveness, cost-utility and cost-benefit, to ensure the payers’ limited funds are well-invested.Participants will leave this event armed with real-life, best practice examples of what is working and not working for your specific product type; what Payers and HTAs consider as essential and “nice to have” information to create “value”; and will have established relationships with the peers from the industry as well as influential decision-makers & KOLs in this sector.4 EVENTS IN ONE:International Medical Device Payer & HTA ForumEvidence Generation for Medical DevicesMarket Access for Surgical & Implantable DevicesMarket Access for Diagnostics & Capital Equipment